Pembrolizumab in patients with recurrent thymic carcinoma: Results of a phase II study.

被引：9

作者：

Giaccone, Giuseppe

Thompson, Jillian

McGuire, Colleen

Manning, Maria

Kallakury, Bhaskar

Chahine, Joeffrey J.

Subramaniam, Deepa Suresh

Liu, Stephen V.

Gibney, Geoffrey Thomas

Kim, Chul

McCutcheon, Justine N.

机构：

[1] Georgetown Univ, Washington, DC USA

[2] Georgetown Univ, Med Ctr, Washington, DC 20007 USA

[3] Georgetown Lombardi Comprehens Canc Ctr, Washington, DC USA

[4] Georgetown Univ Hosp, Lombardi Comprehens Canc Ctr, Washington, DC 20007 USA

[5] NIH, NCI, Thorac & Gastrointestinal Oncol Branch, Ctr Canc Res, Bldg 10, Bethesda, MD 20892 USA

来源：

关键词：

D O I：

10.1200/JCO.2017.35.15_suppl.8573

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

8573

引用

页数：5